Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products …

LAVAL, QUÉBEC–(Marketwired – Feb. 12, 2018) – Neptune Technologies Bioressources Inc. (“Neptune”) (NASDAQ:NEPT)(TSX:NEPT) and Tetra Bio-Pharma Inc. (“Tetra”) (TSX VENTURE:TBP)(OTCQB:TBPMF) today announced that they entered into an agreement for the co-development, commercialization and marketing of purified cannabinoid oil-based products to address pain and inflammation relief applications for the natural health products and pet veterinary markets.

“We are excited to partner with Tetra, a biopharmaceutical leader in the development of cannabinoid-based novel drugs and treatments. The products that will be co-developed will be supported by research as well as our unique formulation and delivery system knowledge, which are key components of

...read more at http://www.marketwired.com/press-release/neptune-tetra-bio-pharma-enter-co-development-agreement-purified-cannabinoid-oil-based-nasdaq-nept-2245645.htm

by